Inhibition studies of quinazoline-sulfonamide derivatives against the γ-CA (PgiCA) from the pathogenic bacterium, Porphyromonas gingivalis

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 30, Issue 4, 2015, Pages 592-596

  Alafeefy, Ahmed M ^a   Ceruso, Mariangela ^b   Al Tamimi, Abdul Malek S ^a   Del Prete, Sonia ^c   Supuran, Claudiu T ^b   Capasso, Clemente ^c  

^a PRINCE SATTAM BIN ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b UNIVERSITY OF FLORENCE   (Italy)

^c CNR   (Italy)

Author keywords

Carbonic anhydrase; periodontitis; Porphyromonas gingivalis; quinazoline; sulfonamide

Indexed keywords

BACTERIAL ENZYME; CARBONATE DEHYDRATASE; GAMMA CARBONIC ANHYDRASE; QUINAZOLINE DERIVATIVE; SULFONAMIDE; UNCLASSIFIED DRUG; CARBONATE DEHYDRATASE INHIBITOR;

ARTICLE; NONHUMAN; PATHOGENESIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; AMINO ACID SEQUENCE; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; KINETICS; MICROBIAL SENSITIVITY TEST; MOLECULAR GENETICS; PHYLOGENY; SEQUENCE HOMOLOGY;

BACTERIA (MICROORGANISMS); MAMMALIA; PORPHYROMONAS GINGIVALIS;

AMINO ACID SEQUENCE; CARBONIC ANHYDRASE INHIBITORS; CARBONIC ANHYDRASES; KINETICS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PHYLOGENY; PORPHYROMONAS GINGIVALIS; QUINAZOLINES; SEQUENCE HOMOLOGY, AMINO ACID; SULFONAMIDES;

EID: 84937203648     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756366.2014.957202     Document Type: Article

References (30)

1. Capasso C, Supuran CT. Sulfa and trimethoprim-like drugs-antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors. J Enzyme Inhib Med Chem 2014;29:379-87.
2. Balsalobre LC, Dropa M, Matté MH. An overview of antimicrobial resistance and its public health significance. Braz J Microbiol 2014; 45:1-5.
3. Capasso C, Supuran CT. An overview of the alpha-, beta-and gamma-carbonic anhydrases from bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria inhibitors? J Enzyme Inhib Med Chem 2014 (in press).
4. Wright GD. Antibiotic resistance in the environment: a link to the clinic. Curr Opin Microbiol 2010;13:589-94.
5. Supuran CT. Structure-based drug discovery of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2012;27:759-72.
6. Supuran CT. Carbonic anhydrases: from biomedical applications of the inhibitors and activators to biotechnologic use for CO2 capture. J Enzyme Inhib Med Chem 2013;28:229-30.
7. Allouche F, Chabchoub F, Carta F, Supuran CT. Synthesis of aminocyanopyrazoles via a multi-component reaction and anticarbonic anhydrase inhibitory activity of their sulfamide derivatives against cytosolic and transmembrane isoforms. J Enzyme Inhib Med Chem 2013;28:343-9.
8. Supuran CT, Carta F, Scozzafava A. Metalloenzyme inhibitors for the treatment of Gram-negative bacterial infections: a patent review (2009-2012). Expert Opin Ther Pat 2013;23:777-88.
9. Supuran CT. Carbonic anhydrases. Bioorg Med Chem 2013;21: 1377-8.
10. Ekinci D, Fidan I, Durdagi S, Kaban Ş, Supuran CT. Kinetic and in silico analysis of thiazolidin-based inhibitors of a-carbonic anhydrase isoenzymes. J Enzyme Inhib Med Chem 2013;28:370-4.
11. McKenna R, Supuran CT. Carbonic anhydrase inhibitors drug design. Subcell Biochem 2014;75:291-323.
12. Nishimori I, Minakuchi T, Morimoto K, et al. Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs. J Med Chem 2006;49: 2117-26.
13. Alafeefy AM, Abdel-Aziz HA, Vullo D, et al. Inhibition of carbonic anhydrases from the extremophilic bacteria Sulfurihydrogenibium yellostonense (SspCA) and S. azorense (SazCA) with a new series of sulfonamides incorporating aroylhydrazone-,1,2,4 triazolo[3,4-b][1,3,4]thiadiazinyl-or 2-(cyanophenylmethylene)-1,3,4-thiadiazol-3(2H)-yl moieties. Bioorg Med Chem 2014;22:141-7.
14. Del Prete S, Isik S, Vullo D, et al. DNA cloning, characterization, and inhibition studies of an a-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. J Med Chem 2012;55:10742-8.
15. Capasso C, Supuran CT. Anti-infective carbonic anhydrase inhibitors: a patent and literature review. Expert Opin Ther Pat 2013;23: 693-704.
16. Maresca A, Carta F, Vullo D, Supuran CT. Dithiocarbamates strongly inhibit the b-class carbonic anhydrases from Mycobacterium tuberculosis. J Enzyme Inhib Med Chem 2013;28: 407-11.
17. Ekinci D, Karagoz L, Ekinci D, et al. Carbonic anhydrase inhibitors: in vitro inhibition of a isoforms (hCA I, hCA II, bCA III, hCA IV) by flavonoids. J Enzyme Inhib Med Chem 2013;28:283-8.
18. Maresca A, Vullo D, Scozzafava A, Supuran CT. Inhibition of the alpha-and beta-carbonic anhydrases from the gastric pathogen Helycobacter pylori with anions. J Enzyme Inhib Med Chem 2013; 28:388-91.
19. Pussinen PJ, Alfthan G, Tuomilehto J, et al. High serum antibody levels to Porphyromonas gingivalis predict myocardial infarction. Eur J Cardiovasc Prev Rehabil 2004;11:408-11.
20. Del Prete S, Vullo D, De Luca V, et al. A highly catalytically active g-carbonic anhydrase from the pathogenic anaerobe Porphyromonas gingivalis and its inhibition profile with anions and small molecules. Bioorg Med Chem Lett 2013;23:4067-71.
21. Del Prete S, De Luca V, Vullo D, et al. Biochemical characterization of the gamma-carbonic anhydrase from the oral pathogen Porphyromonas gingivalis, PgiCA. J Enzyme Inhib Med Chem 2014;29:532-7.
22. Vullo D, Del Prete S, Osman SM, et al. Sulfonamide inhibition studies of the gamma-carbonic anhydrase from the oral pathogen Porphyromonas gingivalis. Bioorg Med Chem Lett 2014;24:240-4.
23. Del Prete S, Vullo D, Osman SM, et al. Sulfonamide inhibition study of the carbonic anhydrases from the bacterial pathogen Porphyromonas gingivalis: the b-class (PgiCAb) versus the g-class (PgiCA) enzymes. Bioorg Med Chem 2014;22:4537-43.
24. Gangjee A, Jain HD, Kurup S. Recent advances in classical and nonclassical antifolates as antitumor and antiopportunistic infection agents: part I. Anticancer Agents Med Chem 2007;7:524-42.
25. Zain JM, Marchi E. Pralatrexate-from bench to bedside. Drugs Today (Barc) 2010;46:91-9.
26. Ford HE. Gefitinib for oesophageal cancer: a cog in need of a wheel? Lancet Oncol 2014;pii:S1470-2045.
27. Writer BW, Meyer EG, Schillerstrom JE. Prazosin for military combat-related PTSD nightmares: a critical review. J Neuropsychiatr Clin Neurosci 2014;26:24-33.
28. Carta F, Temperini C, Innocenti A, et al. Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule. J Med Chem 2010;53:5511-22.
29. Koz O, Ekinci D, Perrone A, et al. Analysis of saponins and phenolic compounds as inhibitors of a-carbonic anhydrase isoenzymes. J Enzyme Inhib Med Chem 2013;28:412-17.
30. Maresca A, Scozzafava A, Vullo D, Supuran CT. Dihalogenated sulfanilamides and benzolamides are effective inhibitors of the three b-class carbonic anhydrases from Mycobacterium tuberculosis. J Enzyme Inhib Med Chem 2013;28:384-7.